Hiroki Yamaguchi
Kanazawa, 9208640, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181.
Journal: The journal of prevention of Alzheimer's disease
Published: May 19, 2026
Higher phosphorylated tau levels predict cognitive decline and amyloid-related imaging abnormalities during lecanemab treatment: clinical practice data.
Journal: Alzheimer's research & therapy
Published: September 22, 2025
Deterioration after Liver Transplantation and Transthyretin Stabilizer Administration in a Patient with ATTRv Amyloidosis with a Leu58Arg (p.Leu78Arg) TTR Variant.
Journal: Internal medicine (Tokyo, Japan)
Published: March 14, 2022
Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis.
Journal: Frontiers in molecular biosciences
Published: December 20, 2021
The Author's Reply: Cerebellar Stroke-like Lesions?
Journal: Internal medicine (Tokyo, Japan)
Published: July 12, 2019
Cerebellar Hyperintensity Lesions on Diffusion-weighted MRI in MELAS.
Journal: Internal medicine (Tokyo, Japan)
Published: February 26, 2019
Autoimmune hepatitis induced by a single injection of interferon-β 1a in a patient with multiple sclerosis.
Journal: Journal of neurology
Published: February 15, 2018
Tracking Rheumatoid Leptomeningitis on Diffusion-weighted MRI.
Journal: Internal medicine (Tokyo, Japan)
Published: June 16, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026